Linda Yaccarino, the former CEO of X (previously known as Twitter), has officially taken the helm at eMed, a telehealth startup focused on weight-loss drug management. Her appointment follows her departure from Elon Musk’s social media platform and marks a significant shift in her career towards the health industry. At eMed, Yaccarino aims to drive innovation in digital health, particularly with GLP-1 medications aimed at weight management. This transition highlights her versatility and the demand for leadership in the burgeoning health tech sector.